The content on this site is intended for healthcare professionals only
OncoAlert Round Up for September 15-21, 2023
Osimertinib plus chemotherapy shows superior results versus osimertinib alone for EGFR-mutated advanced lung cancer
The 5-year long-term outcomes of radiation technique for locally advanced NSCLC
A reproducibility study in pulmonary adenocarcinomas supports a revised classification
OncoAlert Round Up for September 1-7, 2023
Reducing stigma for lung cancer and other smoking-related respiratory diseases
Part 6: Which different PARP inhibitors are available
Part 7: Similarities and Differences
Part 8: How PARP inhibitors are being used now
Part 9: What PARP inhibitors mean for the future and what to look out for
The Vietnam National Cancer Institute’s efforts in improving cancer care in Vietnam
Cancer control initiatives at the National Cancer Center Korea
